Mapping the energy surface of transmembrane helix-helix interactions

Biophysical Journal
J TorresI T Arkin

Abstract

Transmembrane helices are no longer believed to be just hydrophobic segments that exist solely to anchor proteins to a lipid bilayer, but rather they appear to have the capacity to specify function and structure. Specific interactions take place between hydrophobic segments within the lipid bilayer whereby subtle mutations that normally would be considered innocuous can result in dramatic structural differences. That such specificity takes place within the lipid bilayer implies that it may be possible to identify the most favorable interaction surface of transmembrane alpha-helices based on computational methods alone, as shown in this study. Herein, an attempt is made to map the energy surface of several transmembrane helix-helix interactions for several homo-oligomerizing proteins, where experimental data regarding their structure exist (glycophorin A, phospholamban, Influenza virus A M2, Influenza virus C CM2, and HIV vpu). It is shown that due to symmetry constraints in homo-oligomers the computational problem can be simplified. The results obtained are mostly consistent with known structural data and may additionally provide a view of possible alternate and intermediate configurations.

References

Dec 29, 1992·Biochemistry·M A LemmonD M Engelman
May 1, 1990·Biochemistry·J L Popot, D M Engelman
Jan 1, 1986·Annual Review of Biophysics and Biophysical Chemistry·D M EngelmanA Goldman
Jan 5, 1981·Journal of Molecular Biology·C ChothiaD Richardson
Mar 1, 1994·Nature Structural Biology·M A LemmonD M Engelman
Jan 1, 1995·Advances in Virus Research·L Carrasco
May 1, 1994·Quarterly Reviews of Biophysics·M A Lemmon, D M Engelman
Dec 1, 1994·The Journal of General Virology·S HongoK Nakamura
Jun 6, 1994·FEBS Letters·M A Lemmon, D M Engelman
Jan 26, 1996·Journal of Molecular Biology·D WaltherP Argos
Apr 4, 1997·Science·K R MacKenzieD M Engelman
Jan 1, 1997·Annual Review of Biophysics and Biomolecular Structure·I T ArkinD M Engelman
Oct 7, 1997·Circulation Research·G ChuE G Kranias
Nov 14, 1997·Nature Structural Biology·J U Bowie
Nov 22, 1997·Journal of Molecular Biology·J U Bowie
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·K R MacKenzie, D M Engelman
Apr 16, 1998·Protein Science : a Publication of the Protein Society·L S CavesM Karplus
Aug 26, 1998·Methods in Enzymology·M S Sansom
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
Dec 5, 1998·The Journal of Biological Chemistry·G ChuE G Kranias
Jan 27, 1999·Biochimica Et Biophysica Acta·I T Arkin, A T Brunger
Jun 18, 1999·Proteins·T J Stevens, I T Arkin

❮ Previous
Next ❯

Citations

Jul 25, 2007·European Biophysics Journal : EBJ·Oumarou Samna SoumanaMonique Genest
Jan 31, 2008·Proceedings of the National Academy of Sciences of the United States of America·Sarah D Cady, Mei Hong
Apr 22, 2005·Journal of Biomolecular Structure & Dynamics·Nagaraju Akula, Nagarajan Pattabiraman
Feb 16, 2002·Protein Science : a Publication of the Protein Society·Che MaStanley J Opella
Aug 18, 2009·Chemistry and Physics of Lipids·Natalie Bordag, Sandro Keller
Feb 22, 2007·Proteins·Douglas G MetcalfWilliam F DeGrado
Sep 2, 2004·Protein Science : a Publication of the Protein Society·Andrei L LomizeH I Mosberg
Mar 16, 2005·Proteins·Vikas Nanda, William F DeGrado
Aug 17, 2010·Biochimica Et Biophysica Acta·Cheng-Chang ChenWolfgang B Fischer
Feb 17, 2005·Biophysical Journal·Jaume TorresDing Xiang Liu
Jun 11, 2004·Biophysical Journal·Kay-Eberhard GottschalkHorst Kessler
Oct 8, 2013·Biophysical Journal·Thuy Hien T NguyenPreston B Moore
Mar 29, 2008·Protein Science : a Publication of the Protein Society·Siok Wan GanJaume Torres
Apr 23, 2008·Current Protocols in Bioinformatics·Uzi KochvaPaul D Adams
Jul 3, 2019·Cells·Janet To, Jaume Torres
Jan 19, 2006·Journal of the American Chemical Society·Vikas Nanda, William F DeGrado
May 4, 2010·Chemistry and Physics of Lipids·Thuy Hien T NguyenPreston B Moore

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.